Top Clinical Trials companies in Belgium by Total Assets

This ranking features the top 5 Clinical Trials companies in Belgium ranked by Total Assets, totaling a Total Assets of USD 18.96 B, for July 05, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in Belgium has the highest Total Assets ?

The Clinical Trials company in Belgium with the highest Total Assets is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 17.96 B.

Which Clinical Trials company in Belgium has the lowest Total Assets ?

The Clinical Trials company in Belgium with the lowest Total Assets is Hyloris Pharmaceuticals SA (Brussels Stock Exchange: HYL.BR) at USD 42.80 M.

What are the top 10 Clinical Trials companies in Belgium by Total Assets ?

The top 10 Clinical Trials companies in Belgium by Total Assets are UCB SA, Ion Beam Applications SA, Nyxoah S.A., MDxHealth SA and Hyloris Pharmaceuticals SA.

What are the bottom 10 Clinical Trials companies in Belgium by Total Assets ?

The bottom 10 Clinical Trials companies in Belgium by Total Assets are Hyloris Pharmaceuticals SA, MDxHealth SA, Nyxoah S.A., Ion Beam Applications SA and UCB SA.